Clinical Trial Update: A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet [Phase 1]

View source ↗

Summary

Phase 1 study comparing pharmacokinetics and safety/tolerability of BR-UPS (Ulipristal Acetate) 5 mg tablet versus Inisia (Ulipristal Acetate) 5 mg tablet was w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• BR-UPS (Ulipristal Acetate)
• Inisia (Ulipristal Acetate)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Uterine Myoma | Phase 1 | Status: WITHDRAWN